Roberta Gentile

Chieti, 66013, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection.

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection.

Journal: Clinical and experimental medicine
Published: January 08, 2023

Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.

Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.

Journal: Scientific reports
Published: March 16, 2022

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.

Journal: Cancers
Published: August 29, 2020

Antibody-Drug Conjugates: The New Frontier of Chemotherapy.

Antibody-Drug Conjugates: The New Frontier of Chemotherapy.

Journal: International journal of molecular sciences
Published: July 14, 2020

EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer.

EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer.

Journal: Oncology reports
Published: June 17, 2020

Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.

Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 16, 2018

Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro.

Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro.

Journal: Journal of cellular physiology
Published: July 28, 2016

A peroxiredoxin-based proteinaceous scaffold for the growth and differentiation of neuronal cells and tumour stem cells in the absence of prodifferentiation agents.

A peroxiredoxin-based proteinaceous scaffold for the growth and differentiation of neuronal cells and tumour stem cells in the absence of prodifferentiation agents.

Journal: Journal of tissue engineering and regenerative medicine
Published: August 05, 2015

Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa.

Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa.

Journal: Journal of cellular physiology
Published: July 17, 2014

Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway.

Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway.

Journal: Journal of cellular biochemistry
Published: January 10, 2013

Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease model.

Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease model.

Journal: Journal of cellular biochemistry
Published: September 25, 2012

Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways.

Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways.

Journal: Acta biomaterialia
Published: October 05, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026